These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36275235)

  • 21. Tuberculosis (TB)-associated immune reconstitution inflammatory syndrome in TB-HIV co-infected patients in Malaysia: prevalence, risk factors, and treatment outcomes.
    Tan HY; Yong YK; Lim SH; Ponnampalavanar S; Omar SF; Pang YK; Kamarulzaman A; Price P; Crowe SM; French MA
    Sex Health; 2014 Dec; 11(6):532-9. PubMed ID: 25200957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High Activation of γδ T Cells and the γδ2
    Pean P; Nouhin J; Ratana M; Madec Y; Borand L; Marcy O; Laureillard D; Fernandez M; Barré-Sinoussi F; Weiss L; Scott-Algara D
    Front Immunol; 2019; 10():2018. PubMed ID: 31507608
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection.
    Worodria W; Menten J; Massinga-Loembe M; Mazakpwe D; Bagenda D; Koole O; Mayanja-Kizza H; Kestens L; Mugerwa R; Reiss P; Colebunders R;
    Antivir Ther; 2012; 17(5):841-8. PubMed ID: 22543224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcome.
    Bonnet M; Baudin E; Jani IV; Nunes E; Verhoustraten F; Calmy A; Bastos R; Bhatt NB; Michon C
    PLoS One; 2013; 8(12):e84585. PubMed ID: 24367678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of CXCR3
    Tibúrcio R; Narendran G; Barreto-Duarte B; Queiroz ATL; Araújo-Pereira M; Anbalagan S; Nayak K; Ravichandran N; Subramani R; Antonelli LRV; Satagopan K; Anbalagan K; Porter BO; Sher A; Swaminathan S; Sereti I; Andrade BB
    Front Immunol; 2022; 13():873985. PubMed ID: 35432354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
    Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome.
    Conesa-Botella A; Loembé MM; Manabe YC; Worodria W; Mazakpwe D; Luzinda K; Mayanja-Kizza H; Miri M; Mbabazi O; Koole O; Kestens L; Colebunders R;
    J Acquir Immune Defic Syndr; 2011 Dec; 58(5):463-8. PubMed ID: 21963941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LPS-binding protein and IL-6 mark paradoxical tuberculosis immune reconstitution inflammatory syndrome in HIV patients.
    Goovaerts O; Jennes W; Massinga-Loembé M; Ceulemans A; Worodria W; Mayanja-Kizza H; Colebunders R; Kestens L;
    PLoS One; 2013; 8(11):e81856. PubMed ID: 24312369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged tuberculosis-associated immune reconstitution inflammatory syndrome: characteristics and risk factors.
    Bana TM; Lesosky M; Pepper DJ; van der Plas H; Schutz C; Goliath R; Morroni C; Mendelson M; Maartens G; Wilkinson RJ; Meintjes G
    BMC Infect Dis; 2016 Sep; 16(1):518. PubMed ID: 27677424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome.
    Chakrabarti LA; Boucherie C; Bugault F; Cumont MC; Roussillon C; Breton G; Patey O; Chêne G; Richert L; Lortholary O;
    AIDS; 2014 Jul; 28(11):1593-602. PubMed ID: 24865974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.
    Naidoo K; Yende-Zuma N; Padayatchi N; Naidoo K; Jithoo N; Nair G; Bamber S; Gengiah S; El-Sadr WM; Friedland G; Abdool Karim S
    Ann Intern Med; 2012 Sep; 157(5):313-24. PubMed ID: 22944873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial.
    Mfinanga SG; Kirenga BJ; Chanda DM; Mutayoba B; Mthiyane T; Yimer G; Ezechi O; Connolly C; Kapotwe V; Muwonge C; Massaga J; Sinkala E; Kohi W; Lyantumba L; Nyakoojo G; Luwaga H; Doulla B; Mzyece J; Kapata N; Vahedi M; Mwaba P; Egwaga S; Adatu F; Pym A; Joloba M; Rustomjee R; Zumla A; Onyebujoh P
    Lancet Infect Dis; 2014 Jul; 14(7):563-71. PubMed ID: 24810491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.
    Haddow LJ; Moosa MY; Mosam A; Moodley P; Parboosing R; Easterbrook PJ
    PLoS One; 2012; 7(11):e40623. PubMed ID: 23152745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrase strand transfer inhibitor treatment does not increase the incidence of immune reconstitution inflammatory syndrome in HIV-infected Koreans.
    Kim J; Nam HJ; Kang SJ; Jung SI; Hwang CH; Kim YS; Chang HH; Kim SW; Park KH
    HIV Med; 2021 Sep; 22(8):705-714. PubMed ID: 34046975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome.
    Tan HY; Yong YK; Andrade BB; Shankar EM; Ponnampalavanar S; Omar SF; Narendran G; Kamarulzaman A; Swaminathan S; Sereti I; Crowe SM; French MA
    AIDS; 2015 Feb; 29(4):421-31. PubMed ID: 25565499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe manifestations of extrapulmonary tuberculosis in HIV-infected children initiating antiretroviral therapy before 2 years of age.
    Walters E; Duvenhage J; Draper HR; Hesseling AC; Van Wyk SS; Cotton MF; Rabie H
    Arch Dis Child; 2014 Nov; 99(11):998-1003. PubMed ID: 24938535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome.
    Conesa-Botella A; Meintjes G; Coussens AK; van der Plas H; Goliath R; Schutz C; Moreno-Reyes R; Mehta M; Martineau AR; Wilkinson RJ; Colebunders R; Wilkinson KA
    Clin Infect Dis; 2012 Oct; 55(7):1004-11. PubMed ID: 22715179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of immune reconstitution inflammatory syndrome on antiretroviral therapy adherence.
    Nachega JB; Morroni C; Chaisson RE; Goliath R; Efron A; Ram M; Maartens G
    Patient Prefer Adherence; 2012; 6():887-91. PubMed ID: 23271897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.
    Manosuthi W; Kiertiburanakul S; Phoorisri T; Sungkanuparph S
    J Infect; 2006 Dec; 53(6):357-63. PubMed ID: 16487593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TB.
    Haridas V; Pean P; Jasenosky LD; Madec Y; Laureillard D; Sok T; Sath S; Borand L; Marcy O; Chan S; Tsitsikov E; Delfraissy JF; Blanc FX; Goldfeld AE;
    AIDS; 2015 Jan; 29(3):263-73. PubMed ID: 25486415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.